“… alive | Ranjan et al [ 41 ] | BVS | male | 47 | headache, aphasia | primary | total | QT/RT,TMZ, nivolumab | yes | KI67(+) | n.a. | alive |
Richard et al [ 42 ] | BVS | male | 28 | seizures | primary | total | QT/RT,TMZ | no | GFAP(+), OLIG2(+), ATRX(+), MKi67(+), MGMT(+) | IDH-1(+),TP53(+), TERT(+) | alive |
Rosen et al [ 43 ] | BVS | female | 48 | aphasia, hemiparesis | primary | partial | QT/RT, TMZ, bevacizumab | yes | MGMT(−) | IDH-1 wt(+) | 13 months |
Wang et al [ 44 ] | BVS | male | 4 | headache, hemiparesis, vomiting | primary | total | QT/RT, bevacizumab, nimotucimab, irinotecan | yes | GFAP(+),VIMENTIN(+),OLIG2(+), S-100(+)ATRX, MGMT(+),MKI67(+) | TP53, IDH-1(+), SMAD3(+), SMARCB1(+) | 8 years |
Bärtschi et al [ 45 ] | BVS | male | 44 | hemiparesis | |
…”